TETRAZOLSUBSTITUIERTE ARYLAMIDE
European patent · EP2038264 · In force
Register entry
- Publication number
- EP2038264
- Application number
- EP07730213
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jun 18, 2007
- Published
- Mar 25, 2009
- Granted
- Oct 26, 2016
- Protection ends at the latest
- Jun 17, 2027
- Next annual fee due
- Jun 30, 2027
- IPC classes
- C07D 241/12 (2006.01)C07D 257/04 (2006.01)C07D 401/10 (2006.01)C07D 401/12 (2006.01)C07D 401/14 (2006.01)C07D 403/10 (2006.01)C07D 403/12 (2006.01)C07D 403/14 (2006.01)C07D 409/12 (2006.01)C07D 471/04 (2006.01)C07D 405/12 (2006.01)C07D 407/10 (2006.01)C07D 413/10 (2006.01)C07D 417/10 (2006.01)C07D 417/12 (2006.01)C07D 491/10 (2006.01)C07D 491/107 (2006.01)C07D 498/08 (2006.01)
- Priority
- US 817298 P 29.06.2006
- PCT application
- PCT/EP2007/055997 18.06.2007
- PCT publication
- WO2008/000645 03.01.2008
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jul 1, 2026
Next annual fee due on
- Next annual fee due on
- 30.06.2026 → 30.06.2027
Published in Swissreg on 01.07.2026
- Jul 1, 2025
Next annual fee due on
- Next annual fee due on
- 30.06.2025 → 30.06.2026
Published in Swissreg on 01.07.2025
- Jul 1, 2024
Change
Published in Swissreg on 01.07.2024
- Jul 1, 2023
Change
Published in Swissreg on 01.07.2023
- Jul 1, 2022
Change
Published in Swissreg on 01.07.2022
- Oct 26, 2016
Granted
Published in Swissreg on 26.10.2016
Parties
Inventor
Shanghai 201203, CN
Shanghai 200030, CN
Mountain View, California 94041, US
Shanghai 201204, CN
San Francisco, CA 94131, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.